Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.

The 26th annual New Cardiovascular Horizons (NCVH) conference brought 1,400 from across the globe to New Orleans to ...

LeMaitre’s revenue and earnings continue to grow, though profit growth has moderated. Click here to read an analysis of LMAT ...

Peripheral Artery Disease is a growing but often overlooked health threat in Southeast Missouri, where high rates of smoking ...